[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 25, 1995


Author Affiliations

St Louis University School of Medicine St Louis, Mo

JAMA. 1995;273(4):353. doi:10.1001/jama.1995.03520280101055

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The first edition of this text about vaccines was successful in providing a comprehensive look at currently available immunizations, future vaccines, and a variety of issues that relate to their use. The six years since the publication of the first edition have yielded a rapid expansion of information and newly released vaccines such as the conjugated vaccine directed against Haemophilus influenzae type b, hepatitis A vaccine, and new typhoid fever vaccines. In addition, much has been learned and applied to new technologies for developing and making vaccines. Recombinant DNA is an example of a new technology that has recently been applied to vaccine development.

The second edition is 50% bigger than the first, reflecting both additional information about existing vaccines and new chapters on the Japanese encephalitis, tick-borne encephalitis, and anthrax vaccines. Useful appendices have been added, which include tables of information about where to find the current Advisory Committee

First Page Preview View Large
First page PDF preview
First page PDF preview